THE WALL STREET JOURNAL / By STEPHEN D. MOORE / Sept. 18, 2000
ZURICH -- As Novartis AG and AstraZeneca PLC step up preparations for the spinoff and merger of their agribusiness divisions, company officials are outlining aggressive new strategies to work with farmers and retailers but aren't promising investors a quick fix to problems besetting the beleaguered industry.